SCHEMBL4361291

SCHEMBL4361291

Oc1ncnc2nc(-c3ccccc3)c(-c3ccccc3)nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 5/20 0.53
▸ ADK P55263 1/20 0.51
▸ ALDH1A1 P00352 6/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ HTT P42858 2/20 0.49
▸ GAA P10253 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ DHFR P00374 1/20 0.45
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ TP53 P04637 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ MAPT P10636 4/20 0.44
▸ POLB P06746 1/20 0.44
▸ ADORA2A P29274 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14983476 0.86 PIK3CG (0.71) PIK3CGADKALDH1A1KDM4EHTT
SCHEMBL1351376 0.82 AKT1 (0.51) —
SCHEMBL14983464 0.81 PIK3CG (0.65) PIK3CGADKALDH1A1KDM4EHTT
Hydrochloric Acid SCHEMBL1351917 0.81 AKT1 (0.50) —
Hydrochloric Acid SCHEMBL1351112 0.81 AKT1 (0.50) —
SCHEMBL14983475 0.79 PIK3CG (0.50) PIK3CGADKALDH1A1KDM4EHPGD
SCHEMBL3742316 0.79 ADK (0.76) PIK3CGADKALDH1A1KDM4EHTT
SCHEMBL17089216 0.78 PIK3CG (0.55) PIK3CGALDH1A1KDM4ETSHRHSD17B10
SCHEMBL3533590 0.76 PIK3CG (0.50) PIK3CGADKALDH1A1KDM4EHTT
SCHEMBL3252241 0.76 PIK3CG (0.48) PIK3CGADKNOS1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2039683-B1 Vasculostatic agents and methods of use thereof TARGEGEN INC (US) 2012-12-19 — — EP disclosed
EP-2039683-A2 Vasculostatic agents and methods of use thereof Targegen, Inc. (US) 2009-03-25 — — EP disclosed
Send feedback